Altin J G, Bygrave F L
Department of Biochemistry, Faculty of Science, Australian National University, Canberra ACT.
Mol Cell Biochem. 1988 Sep;83(1):3-14. doi: 10.1007/BF00223193.
Parenchymal cells (hepatocytes) are the sites at which the principal metabolic functions of the liver are located. In the perfused liver, responses (e.g. vasoconstriction and glycogenolysis) to stimulating agents such as zymosan, platelet-activating factor and arachidonic acid, are inhibited by indomethacin and bromophenacyl bromide, inhibitors of cyclo-oxygenase and phospholipase A2, respectively. Since cultured Kupffer and endothelial cells but not hepatocytes, produce eicosanoids, and since eicosanoids and especially prostaglandins induce similar patterns of responses when added directly to the perfused liver, an involvement of these non-parenchymal cells in mediating the above responses is considered likely. We propose that in most situations the responses induced by these stimulating agents are mediated through a combination of pathways that include interaction of the agents directly with hepatocytes or with vasoactive cells (endothelial and/or smooth muscle cells), or interaction of agents initially with non-parenchymal cells to produce and release eicosanoids, which then subsequently interact with hepatocytes or with vasoactive cells.
实质细胞(肝细胞)是肝脏主要代谢功能所在的部位。在灌注肝脏中,对诸如酵母聚糖、血小板活化因子和花生四烯酸等刺激剂的反应(如血管收缩和糖原分解)分别被环氧化酶抑制剂吲哚美辛和磷脂酶A2抑制剂溴苯甲酰溴所抑制。由于培养的库普弗细胞和内皮细胞而非肝细胞能产生类花生酸,并且由于类花生酸尤其是前列腺素直接添加到灌注肝脏时会诱导相似的反应模式,因此认为这些非实质细胞可能参与介导上述反应。我们提出,在大多数情况下,这些刺激剂诱导的反应是通过多种途径介导的,这些途径包括刺激剂直接与肝细胞或血管活性细胞(内皮细胞和/或平滑肌细胞)相互作用,或者刺激剂最初与非实质细胞相互作用以产生和释放类花生酸,然后类花生酸再与肝细胞或血管活性细胞相互作用。